Abstract
Specimen identification through DNA analysis is an approach to solve several conundrums that may arise during the course of routine laboratory testing. In this chapter methods for specimen identification by DNA analysis are described, including specimen selection and specimen preparation, genotyping approaches, and result interpretation. Clinical applications for these methods are discussed, and example cases demonstrate how the methods can be applied to solve relevant problems such as identification of misidentified specimens, unexpected tissue in a specimen, maternal contamination of a prenatal diagnostic specimen, diagnosis of donor-associated malignancies, graft-vs-host disease, as well as gestational trophoblastic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tsongalis GJ, Berman MM. Application of forensic identity testing in a clinical setting. Specimen identification. Diagn Mol Pathol. 1997;6:111–4.
Pfeifer JD, Zehnbauer B, Payton J. The changing spectrum of DNA-based specimen provenance testing in surgical pathology. Am J Clin Pathol. 2011;135:132–8.
Abeln EC, van Kemenade FD, van Krieken JH, Cornelisse CJ. Rapid identification of mixed up bladder biopsy specimens using polymorphic microsatellite markers. Diagn Mol Pathol. 1995;4:286–91.
Hunt JL, Swalsky P, Sasatomi E, Niehouse L, Bakker A, Finkelstein SD. A microdissection and molecular genotyping assay to confirm the identity of tissue floaters in paraffin-embedded tissue blocks. Arch Pathol Lab Med. 2003;127:213–7.
Shibata D, Kurosu M, Noguchi TT. Fixed human tissues: a resource for the identification of individuals. J Forensic Sci. 1991;36:1204–12.
Hunt JL. Molecular pathology in anatomic pathology practice: a review of basic principles. Arch Pathol Lab Med. 2008;132:248–60.
Keep D, Zaragoza MV, Hassold T, Redline RW. Very early complete hydatidiform mole. Hum Pathol. 1996;27:708–13.
Murphy KM, McConnell TG, Hafez MJ, Vang R, Ronnett BM. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. J Mol Diagn. 2009;11:598–605.
Antoniadi T, Yapijakis C, Kaminopetros P, et al. A simple and effective approach for detecting maternal cell contamination in molecular prenatal diagnosis. Prenat Diagn. 2002;22:425–9.
Winsor EJ, Akoury H, Chitayat D, Steele L, Stockley TL. The role of molecular microsatellite identity testing to detect sampling errors in prenatal diagnosis. Prenat Diagn. 2010;30:746–52.
Barallon R, Bauer SR, Butler J, et al. Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell Dev Biol Anim. 2010;46:727–32.
Saad R. Discovery, development, and current applications of DNA identity testing. Proc (Bayl Univ Med Cent). 2005;18:130–3.
Gandhi MJ, Strong DM. Donor derived malignancy following transplantation: a review. Cell Tissue Bank. 2007;8:267–86.
Pfeifer JD, Liu J. Rate of occult specimen provenance complications in routine clinical practice. Am J Clin Pathol. 2013;139:93–100.
Marberger M, McConnell JD, Fowler I, et al. Biopsy misidentification identified by DNA profiling in a large multicenter trial. J Clin Oncol. 2011;29:1744–9.
Michel R. Laboratory compliance watch: In-practice histology lab splits biopsies; ID’s patient with DNA. The Dark Report 2011 October 12:10.
Tsongalis GJ, Wu AH, Silver H, Ricci Jr A. Applications of forensic identity testing in the clinical laboratory. Am J Clin Pathol. 1999;112:S93–103.
Tsongalis GJ, Anamani DE, Wu AH. Identification of urine specimen donors by the PM+DQA1 amplification and typing kit. J Forensic Sci. 1996;41:1031–4.
Linfert DR, Wu AH, Tsongalis GJ. The effect of pathologic substances and adulterants on the DNA typing of urine. J Forensic Sci. 1998;43:1041–5.
Butler JM. Genetics and genomics of core short tandem repeat loci used in human identity testing. J Forensic Sci. 2006;51:253–65.
Huijsmans CJ, Heilmann FG, van der Zanden AG, Schneeberger PM, Hermans MH. Single nucleotide polymorphism profiling assay to exclude serum sample mix-up. Vox Sang. 2007;92:148–53.
Huijsmans R, Damen J, van der Linden H, Hermans M. Single nucleotide polymorphism profiling assay to confirm the identity of human tissues. J Mol Diagn. 2007;9:205–13.
Budowle B, Wilson MR, DiZinno JA, et al. Mitochondrial DNA regions HVI and HVII population data. Forensic Sci Int. 1999;103:23–35.
Alonso A, Alves C, Suarez-Mier MP, et al. Mitochondrial DNA haplotyping revealed the presence of mixed up benign and neoplastic tissue sections from two individuals on the same prostatic biopsy slide. J Clin Pathol. 2005;58:83–6.
Pfeifer JD, Singleton MN, Gregory MH, Lambert DL, Kymes SM. Development of a decision-analytic model for the application of STR-based provenance testing of transrectal prostate biopsy specimens. Value Health. 2012;15:860–7.
Paxton A. Unmasking specimen ID errors every step of the way. CAP Today 2010.
Platt E, Sommer P, McDonald L, Bennett A, Hunt J. Tissue floaters and contaminants in the histology laboratory. Arch Pathol Lab Med. 2009;133:973–8.
Birkeland SA, Storm HH. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation. 2002;74:1409–13.
Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Cancer transmission from organ donors-unavoidable but low risk. Transplantation. 2012;94:1200–7.
Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors1. Transplantation. 2002;73:579–82.
Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–56.
Verdonk RC, Haagsma EB, Jongsma T, et al. A prospective analysis of the natural course of donor chimerism including the natural killer cell fraction after liver transplantation. Transplantation. 2011;92:e22–4.
Taylor AL, Gibbs P, Sudhindran S, et al. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation. 2004;77:441–6.
Frederickson RM, Wang HS, Surh LC. Some caveats in PCR-based prenatal diagnosis on direct amniotic fluid versus cultured amniocytes. Prenat Diagn. 1999;19:113–7.
Stojilkovic-Mikic T, Mann K, Docherty Z, Mackie OC. Maternal cell contamination of prenatal samples assessed by QF-PCR genotyping. Prenat Diagn. 2005;25:79–83.
Nagan N, Faulkner NE, Curtis C, Schrijver I. Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathology. J Mol Diagn. 2011;13:7–11.
Schrijver I, Cherny SC, Zehnder JL. Testing for maternal cell contamination in prenatal samples: a comprehensive survey of current diagnostic practices in 35 molecular diagnostic laboratories. J Mol Diagn. 2007;9:394–400.
Winsor EJ, Silver MP, Theve R, Wright M, Ward BE. Maternal cell contamination in uncultured amniotic fluid. Prenat Diagn. 1996;16:49–54.
Genest DR. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol. 2001;20:315–22.
Hui P. Molecular diagnosis of gestational trophoblastic disease. Expert Rev Mol Diagn. 2010;10:1023–34.
Morikawa T, Shima K, Kuchiba A, et al. No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections. Am J Clin Pathol. 2012;138:122–9.
Hunt JL, Finkelstein SD. Microdissection techniques for molecular testing in surgical pathology. Arch Pathol Lab Med. 2004;128:1372–8.
Fend F, Kremer M, Quintanilla-Martinez L. Laser capture microdissection: methodical aspects and applications with emphasis on immuno-laser capture microdissection. Pathobiology. 2000;68:209–14.
Wang XQ, Lo CM, Chen L, et al. Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology. 2012;56:1557–66.
Schoniger-Hekele M, Muller C, Kramer L, et al. Graft versus host disease after orthotopic liver transplantation documented by analysis of short tandem repeat polymorphisms. Digestion. 2006;74:169–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bocsi, G., Ricci, A., Tsongalis, G.J., Van Deerlin, V.M. (2016). Specimen Identification Through DNA Analysis. In: Leonard, D. (eds) Molecular Pathology in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-19674-9_57
Download citation
DOI: https://doi.org/10.1007/978-3-319-19674-9_57
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19673-2
Online ISBN: 978-3-319-19674-9
eBook Packages: MedicineMedicine (R0)